Health/Up and coming

Mytos

Mytos runs an automated contract manufacturing service that uses its iDEM robotic platform to produce stem cell derived therapies.

mytos.bio ↗

Why it's here

Launched an automated CDMO in October 2025 with its first site inside CGT Catapult's Stevenage centre, targeting clinical readiness by September 2026.

source: biospace.com

Focus: Cell therapy manufacturing
Founded: 2016
Total raised: $24Msource: jobs.deepscienceventures.com
Latest round: Series A, $19M, Nov 2023
Staff (Companies House accounts): 27, average over the period to 31 Dec 2025source: find-and-update.company-information.service.gov.uk
Registered office: Translation and Innovation Hub, 84 Wood Lane, London, Hammersmith and Fulham W12 0BZsource: find-and-update.company-information.service.gov.uk
London presence: HQsource: biospace.com
Investors: Buckley Ventures (lead), IQ Capital, Wing VCsource: forbesargentina.com
Y Combinatorsource: jobs.deepscienceventures.com
Accelerator: Y Combinator S18source: ycombinator.com
Area: White City & Shepherd's Bush
Nearest station: White City, 424 m
Companies House: MYTOS BIO LIMITED (09957823, active)Incorporated 19 Jan 2016 · SIC 26511
Hiring: 11 open roles in London ↗Public job board, checked 9 Oct 2026
Work model: On-site (from 11 London job posts)Current job posts only, checked 9 Oct 2026. Howsource: jobs.lever.co
Visas: Licensed visa sponsor, listed as Mytos Bio Limitedsource: gov.uk

Verified 8 Oct 2026. How we verify · Suggest a fix

For Mytos

More Health in London